VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > GE has 40% of the ultrasound market and will direct

<< Previous

Bullboard Posts

Next >>

Comment by LandCruiser1983on Apr 28, 2021 6:03pm

190 Views

Post# 33087763

RE:RE:RE:RE:RE:GE has 40% of the ultrasound market and will direct

Well said. I love these "prophet" who feel it is their duty to save us from/??? what exactly. Is Mustang suggesting VPT is a scam? or trying to get in at a lower price point. I,for one ,have an expectation of a gradual price rise and eventual buy out. Long VPT.

<< Previous

Bullboard Posts

Next >>

Questerre Energy applauds Québec tabling Bill 69